Bruck Kifle

Array ( [id] => 4823216 [patent_doc_number] => 20080227770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Benzoxazepine Compound' [patent_app_type] => utility [patent_app_number] => 10/566883 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74488 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227770.pdf [firstpage_image] =>[orig_patent_app_number] => 10566883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760737 [patent_doc_number] => 20060211682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes' [patent_app_type] => utility [patent_app_number] => 10/566235 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18698 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211682.pdf [firstpage_image] =>[orig_patent_app_number] => 10566235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256516 [patent_doc_number] => 20050143370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/898653 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6404 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143370.pdf [firstpage_image] =>[orig_patent_app_number] => 10898653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634290 [patent_doc_number] => 07129347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Method for purifying caprolactam from waste containing polyamide using UV radiation' [patent_app_type] => utility [patent_app_number] => 10/897472 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4566 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129347.pdf [firstpage_image] =>[orig_patent_app_number] => 10897472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307464 [patent_doc_number] => 07531530 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/565308 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 6407 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531530.pdf [firstpage_image] =>[orig_patent_app_number] => 10565308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853026 [patent_doc_number] => 07378410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Substituted lactams and their use as anti-cancer agents' [patent_app_type] => utility [patent_app_number] => 10/565700 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16128 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378410.pdf [firstpage_image] =>[orig_patent_app_number] => 10565700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869144 [patent_doc_number] => 07365195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Process for purifying caprolactam' [patent_app_type] => utility [patent_app_number] => 10/565774 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4493 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365195.pdf [firstpage_image] =>[orig_patent_app_number] => 10565774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609791 [patent_doc_number] => 06998398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Solid salts of benzazepine compounds and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/890392 [patent_app_country] => US [patent_app_date] => 2004-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4051 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998398.pdf [firstpage_image] =>[orig_patent_app_number] => 10890392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782829 [patent_doc_number] => 06992077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-31 [patent_title] => 'Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/890408 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31737 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/992/06992077.pdf [firstpage_image] =>[orig_patent_app_number] => 10890408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691041 [patent_doc_number] => 07074804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'CCI-779 Isomer C' [patent_app_type] => utility [patent_app_number] => 10/889247 [patent_app_country] => US [patent_app_date] => 2004-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5863 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074804.pdf [firstpage_image] =>[orig_patent_app_number] => 10889247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7155940 [patent_doc_number] => 20050026868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Phosphorus-containing macrocycles' [patent_app_type] => utility [patent_app_number] => 10/889163 [patent_app_country] => US [patent_app_date] => 2004-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15074 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026868.pdf [firstpage_image] =>[orig_patent_app_number] => 10889163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089907 [patent_doc_number] => 20050010020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Method for producing epsilon-caprolactam' [patent_app_type] => utility [patent_app_number] => 10/883822 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20050010020.pdf [firstpage_image] =>[orig_patent_app_number] => 10883822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931180 [patent_doc_number] => 06979684 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-27 [patent_title] => 'Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/881729 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5022 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979684.pdf [firstpage_image] =>[orig_patent_app_number] => 10881729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979105 [patent_doc_number] => 06930109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene' [patent_app_type] => utility [patent_app_number] => 10/878777 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7995 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930109.pdf [firstpage_image] =>[orig_patent_app_number] => 10878777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632320 [patent_doc_number] => 20060148790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Benzodiazepine cgrp receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/562298 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16785 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148790.pdf [firstpage_image] =>[orig_patent_app_number] => 10562298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649776 [patent_doc_number] => 20060135511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Benzodiazepine cgrp receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/562297 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17262 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135511.pdf [firstpage_image] =>[orig_patent_app_number] => 10562297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189123 [patent_doc_number] => 20070167432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Tricyclic triazolobenzapine derivative produced as novel crystalline substance' [patent_app_type] => utility [patent_app_number] => 10/561211 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3024 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167432.pdf [firstpage_image] =>[orig_patent_app_number] => 10561211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154945 [patent_doc_number] => 20070037828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Pyrazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/560966 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15309 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037828.pdf [firstpage_image] =>[orig_patent_app_number] => 10560966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7319164 [patent_doc_number] => 20040224959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same' [patent_app_type] => new [patent_app_number] => 10/868006 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82355 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224959.pdf [firstpage_image] =>[orig_patent_app_number] => 10868006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7319222 [patent_doc_number] => 20040224976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Azabicyclic compounds for the treatment of disease' [patent_app_type] => new [patent_app_number] => 10/868637 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42615 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224976.pdf [firstpage_image] =>[orig_patent_app_number] => 10868637 [rel_patent_id] =>[rel_patent_doc_number] =>)